A
Allarity Therapeutics, Inc. (ALLR)
NCM – Real Time Price. Currency in USD
1.30
+0.03 (2.36%)
At close: Jun 26, 2026, 4:00 PM EDT
1.33
+0.03 (2.07%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.30
+0.03 (2.36%)
At close: Jun 26, 2026, 4:00 PM EDT
1.33
+0.03 (2.07%)
After-hours: Jun 26, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $29.8M significantly exceed its total debt $21.5M, ensuring strong financial flexibility
Total current assets $34.5M exceed Total current liabilities $28.0M, highlighting excellent liquidity
Debt-to-equity ratio (3.1) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-11.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$4.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.23 | 6.05 | 7.0 | |
| Quick ratio | 1.23 | 5.63 | 7.0 | |
| Debt to Equity | 3.11 | 0.30 | 2.0 | |
| Debt to Assets | 0.62 | 1.04 | 3.0 | |
| Interest coverage | -11.74 | -16.91 | 1.0 | |
| Weighted average score | 4.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 320K | 345K |
| Gross Profit | -120K | -37K | -9K | 333K | 351K |
| Operating Income | -17M | -18M | -18M | -14M | -12M |
| Net Income | -16M | -12M | -25M | -11M | -11M |
| EBITDA | -17M | -18M | -18M | -14M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -66.67 | 1.0 |
| Next quarter | N/A | -31.58 | 1.0 |
| Current year | -100 | -17.95 | 1.0 |
| Next year | N/A | -5.43 | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -92.18 | 18.47 | 10.53 | -40.16 | 4.5 |
| Y/Y | 999 | -0.65 | 32 | -69.65 | 5.5 |
| 3y average | 999 | -8.62 | 97.39 | 0.6 | 5.8 |
| 5y average | 999 | -57.95 | N/A | -23.49 | 3.3 |
| Weighted average score | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |